Tag: Spdr S&P Biotech Etf

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

Stocks making the biggest moves midday: Palantir, Flutter, United Airlines, Synopsys, Insmed & more

How CNBC Cures is bringing rare disease stories to a national audience

Vertex passes key test in quest to treat kidney diseases

FDA vaccine head will step down in April after string of controversial decisions

FDA reversals leave investors worrying about the fates of other experimental drugs

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

Three decades into cystic fibrosis fight, Boomer Esiason and his son Gunnar are winning

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal